We protect your health through science

Investigation

Viral Biology

Research Lines

Content with Investigacion Leishmaniasis y Enfermedad de Chagas .

Leishmaniasis y Enfermedad de Chagas

null

Research projects

Content with Investigacion Leishmaniasis y Enfermedad de Chagas .

Publications

Sort
Category

Encephalitis associated with human herpesvirus-7 infection in an immunocompetent adult.

M. Parra; A. Alcala; C. Amoros; A. Baeza; A. Galiana; D. Tarragó; M.Á. García-Quesada; V. Sánchez-Hellín. Encephalitis associated with human herpesvirus-7 infection in an immunocompetent adult. Virology Journal. 14 - 1, 2017.

PUBMED DOI

Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain.

M. Cabrerizo; M. Díaz-Cerio; C. Muñoz-Almagro; N. Rabella; D. Tarragó; M.P. Romero; M.J. Pena; C. Calvo; S. Rey-Cao; A. Moreno-Docón; I. Martínez-Rienda; A. Otero; G. Trallero. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain. J Med Virol. 2017 Mar;89(3):435-442.

PUBMED DOI

Viral epidemic outbreaks and public health alerts studied at the National Centre of Microbiology during a two-year period (2012-2013).

J.M. Echevarría Mayo; A.A. Avellón Calvo; M. Cabrerizo Sanz; I. Casas Flecha; J.E. Echevarría Mayo; Fd.eO. de Ory Manchón; A. Negredo Antón; F. Pozo Sánchez; M.P. Sánchez-Seco Fariñas; D. Tarragó Asensio; G. Trallero Masó. Viral epidemic outbreaks and public health alerts studied at the National Centre of Microbiology during a two-year period (2012-2013). Revista española de salud pública. 90, pp. E16 - E16. 2016

PUBMED

Application of a commercial immunoblot to define EBV IgG seroprofiles.

F. de Ory; E. Guisasola; D. Tarragó; J.C. Sanz. Application of a commercial immunoblot to define EBV IgG seroprofiles. Journal of Clinical Laboratory Analysis. 29 - 1, pp. 47 - 51. 2015.

PUBMED DOI

Content with Investigacion Referencia e Investigación en Helmintos .

List of staff

Additional Information

The research activity of the Viral Biology group since its beginnings in the 1980s has focused on respiratory viruses, especially on the study of the mechanisms of virus entry into the cell, evolutionary aspects, antigenic properties and vaccine development.

Currently, the group's objectives are focused on the characterisation of the immune response and the development of vaccines against human pneumoviruses: human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV).

Both viruses are considered to be important respiratory pathogens of high clinical relevance, especially in the paediatric population.

Safe and effective vaccines against these viruses are currently not available.  Soluble protein subunits based on the fusion protein (F-protein) of hRSV and hMPV are being developed in the laboratory by protein engineering for use as vaccines against human pneumoviruses.

On the other hand, and thanks to the characterisation of the type of humoral response induced by the F proteins of these viruses, the laboratory is also involved in the isolation of monoclonal antibodies and nanoantibodies for use as treatments against these viruses.

The research activity of the Viral Biology group since its beginnings in the 1980s has focused on respiratory viruses, especially on the study of the mechanisms of virus entry into the cell, evolutionary aspects, antigenic properties and vaccine development.

Currently, the group's objectives are focused on the characterisation of the immune response and the development of vaccines against human pneumoviruses: human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV).

Both viruses are considered to be important respiratory pathogens of high clinical relevance, especially in the paediatric population.

Safe and effective vaccines against these viruses are currently not available.  Soluble protein subunits based on the fusion protein (F-protein) of hRSV and hMPV are being developed in the laboratory by protein engineering for use as vaccines against human pneumoviruses.

On the other hand, and thanks to the characterisation of the type of humoral response induced by the F proteins of these viruses, the laboratory is also involved in the isolation of monoclonal antibodies and nanoantibodies for use as treatments against these viruses.

Content with Investigacion Referencia e Investigación en Helmintos .